1738 studies found for:    pancreatic cancer
Show Display Options
Rank Status Study
21 Recruiting Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer
Conditions: Cancer of Pancreas;   Cancer of the Pancreas;   Neoplasms, Pancreatic;   Pancreas Cancer;   Pancreas Neoplasms
Interventions: Drug: Modified FOLFIRINOX;   Radiation: Stereotactic Body Radiotherapy (SBRT)
22 Recruiting Gemcitabine and CT-011 for Resected Pancreatic Cancer
Conditions: Pancreatic Neoplasms;   Cancer of the Pancreas;   Neoplasms Pancreatic;   Pancreatic Cancer;   Pancreas Cancer
Interventions: Biological: CT-011;   Drug: Gemcitabine
23 Terminated A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas
Condition: Pancreatic Cancer
Interventions: Drug: CC-5013;   Drug: gemcitabine
24 Recruiting BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial
Condition: Metastatic Pancreatic Cancer
Intervention: Drug: FOLFOXA
25 Unknown  Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer
Conditions: Pancreatic Cancer;   Pancreas Neoplasms
Intervention: Biological: VEGFR1-A24-1084 (SYGVLLWEI)
26 Active, not recruiting BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study
Condition: Metastatic Pancreatic Cancer
Intervention: Drug: FOLFOX-A
27 Recruiting Neoadjuvant FIRINOX for Borderline Resectable Pancreatic Cancer - a Pilot Study
Condition: Pancreatic Cancer.
Intervention: Drug: FIRINOX
28 Completed Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer
Conditions: Drug/Agent Toxicity by Tissue/Organ;   Pancreatic Cancer
Interventions: Drug: fluorouracil;   Drug: gemcitabine hydrochloride;   Drug: triacetyluridine
29 Recruiting DCE MRI in Diagnosing Patients With Pancreatic Cancer
Conditions: Hereditary Pancreatic Cancer;   Intraductal Papillary Mucinous Neoplasm of the Pancreas;   Recurrent Pancreatic Cancer;   Stage III Pancreatic Cancer;   Stage IV Pancreatic Cancer
Intervention: Procedure: dynamic contrast-enhanced magnetic resonance imaging
30 Recruiting Functional Magnetic Resonance Imaging of Pancreatic Cancer: a Feasibility and Reproducibility Study
Condition: Pancreatic Cancer
Intervention: Drug: Gadobutrol
31 Terminated A Pilot Study, Evaluating the Efficacy of Regulatory T-cell Suppression by Ontak in Metastatic Pancreatic Cancer
Condition: Metastatic Pancreatic Cancer
Intervention: Drug: Ontak
32 Recruiting Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Mirtazapine plus gemcitabine;   Drug: Gemcitabine, placebo
33 Terminated Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer
Conditions: Pancreatic Neoplasms;   Pancreatic Cancer
Intervention: Drug: RTA 402
34 Enrolling by invitation A Phase III Study of Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention:
35 Completed Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Condition: Metastatic Pancreatic Cancer
Interventions: Biological: bavituximab;   Drug: Gemcitabine
36 Recruiting Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Conditions: Pancreatic Cancer;   Stage IV Pancreatic Cancer
Intervention: Drug: OMP-54F28, Nab-Paclitaxel and Gemcitabine
37 Recruiting A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer
Conditions: Pancreatic Cancer;   Stage IV Pancreatic Cancer
Interventions: Drug: Vantictumab;   Drug: Nab-Paclitaxel;   Drug: Gemcitabine
38 Recruiting Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer
Conditions: Bile Duct Cancer;   Pancreatic Cancer
Intervention: Drug: Cox2 inhibitor (Celecoxib)
39 Completed Identification of Biomarkers for Early Detection of Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Genetic: protein expression analysis;   Other: laboratory biomarker analysis;   Other: mass spectrometry;   Other: surface-enhanced laser desorption/ionization-time of flight mass spectrometry
40 Recruiting Pancreatic Cancer Early Detection Program
Conditions: Pancreatic Cancer;   Pancreas Cancer;   Pancreatic Adenocarcinoma;   Familial Pancreatic Cancer;   BRCA 1/2;   HNPCC;   Lynch Syndrome;   Hereditary Pancreatitis;   FAMMM;   Familial Atypical Multiple Mole Melanoma;   Peutz Jeghers Syndrome
Interventions: Procedure: Endoscopic Ultrasound;   Procedure: Magnetic Resonance Imaging (MRI)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years